Literature DB >> 2544281

GR43175 does not share the complex pharmacology of the ergots.

W Feniuk1, P P Humphrey, M J Perren.   

Abstract

The aim of this study was to compare the effects of the selective 5-HT1-like receptor agonist, GR43175, with several ergot derivatives in several different pharmacological preparations. In the rat isolated uterus, ergotamine, dihydroergotamine, ergometrine and methylergometrine (all at concentrations of 1 microM) caused marked uterotonic activity whilst GR43175 (10 and 30 microM) was inactive. Similarly, in the pithed rat the ergot derivatives caused marked increases in diastolic blood pressure (in doses up to 1000 micrograms/kg intravenously), whilst GR43175 (in doses up to 1000 micrograms/kg intravenously) was inactive. In anaesthetized dogs, both ergotamine (0.3-1000 micrograms/kg intravenously) and GR43175 (1-1000 micrograms/kg intravenously) caused dose-dependent vasoconstriction in the carotid artery bed. However, the effects of ergotamine, unlike those of GR43175, were accompanied by increases in diastolic blood pressure and coronary vasoconstriction. These studies provide further evidence for the remarkably selective vasoconstrictor action of GR43175.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544281     DOI: 10.1111/J.1468-2982.1989.TB00070.X

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  6 in total

Review 1.  Safety of sumatriptan in pregnancy: a review of the data so far.

Authors:  Elizabeth Loder
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.

Authors:  S J MacLennan; G R Martin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

Review 3.  Rationale for the use of 5-HT1-like agonists in the treatment of migraine.

Authors:  W Feniuk; P P Humphrey; M J Perren; H E Connor; E T Whalley
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

Review 4.  5-Hydroxytryptamine and the pathophysiology of migraine.

Authors:  P P Humphrey
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

Review 5.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

6.  Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.

Authors:  T M Cocks; B K Kemp; D Pruneau; J A Angus
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.